Main Street Financial Solutions LLC Sells 507 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Main Street Financial Solutions LLC lessened its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 23.5% during the fourth quarter, Holdings Channel reports. The institutional investor owned 1,648 shares of the healthcare conglomerate’s stock after selling 507 shares during the quarter. Main Street Financial Solutions LLC’s holdings in UnitedHealth Group were worth $834,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors also recently added to or reduced their stakes in the company. Stenger Family Office LLC purchased a new position in shares of UnitedHealth Group in the fourth quarter worth about $4,932,000. Lifelong Wealth Advisors Inc. bought a new stake in UnitedHealth Group during the 4th quarter valued at $317,000. Acorns Advisers LLC boosted its holdings in shares of UnitedHealth Group by 31.5% in the fourth quarter. Acorns Advisers LLC now owns 468 shares of the healthcare conglomerate’s stock worth $237,000 after acquiring an additional 112 shares during the period. Operose Advisors LLC raised its stake in shares of UnitedHealth Group by 39.7% during the 4th quarter. Operose Advisors LLC now owns 1,573 shares of the healthcare conglomerate’s stock valued at $796,000 after purchasing an additional 447 shares during the period. Finally, United Capital Financial Advisors LLC grew its holdings in UnitedHealth Group by 0.6% during the 4th quarter. United Capital Financial Advisors LLC now owns 73,746 shares of the healthcare conglomerate’s stock valued at $37,305,000 after buying an additional 447 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the firm’s stock in a transaction on Friday, January 17th. The shares were acquired at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the transaction, the director now owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Trading Up 0.3 %

UnitedHealth Group stock opened at $585.30 on Thursday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The stock has a market capitalization of $535.38 billion, a PE ratio of 37.76, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61. The business’s fifty day moving average is $516.05 and its 200 day moving average is $542.41. UnitedHealth Group Incorporated has a one year low of $438.50 and a one year high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $5.83 earnings per share. On average, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were issued a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.44%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s dividend payout ratio is 54.19%.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on UNH shares. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $700.00 target price on shares of UnitedHealth Group in a report on Friday, January 17th. Barclays reduced their target price on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research report on Friday, January 17th. KeyCorp reiterated an “overweight” rating and set a $650.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. Piper Sandler dropped their price target on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research note on Thursday, January 2nd. Finally, Hsbc Global Res upgraded UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. Twenty-one analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, UnitedHealth Group presently has an average rating of “Buy” and an average price target of $632.85.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.